» Articles » PMID: 6519667

Use of Cyclosporin A in Establishing Epstein-Barr Virus-transformed Human Lymphoblastoid Cell Lines

Overview
Journal In Vitro
Date 1984 Nov 1
PMID 6519667
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.

Citing Articles

Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L variant and study of organoids towards treatment.

Portales-Castillo I, Singal R, Ambrose A, Song J, Son M, Goo Y JIMD Rep. 2024; 65(5):341-353.

PMID: 39544690 PMC: 11558468. DOI: 10.1002/jmd2.12442.


Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitis.

Ghasempour S, Warner N, Guan R, Rodari M, Ivanochko D, Whittaker Hawkins R J Exp Med. 2024; 221(12).

PMID: 39526957 PMC: 11554753. DOI: 10.1084/jem.20240546.


Splice modulators target PMS1 to reduce somatic expansion of the Huntington's disease-associated CAG repeat.

McLean Z, Gao D, Correia K, Roy J, Shibata S, Farnum I Nat Commun. 2024; 15(1):3182.

PMID: 38609352 PMC: 11015039. DOI: 10.1038/s41467-024-47485-0.


Mapping disease regulatory circuits at cell-type resolution from single-cell multiomics data.

Chen X, Wang Y, Cappuccio A, Cheng W, Zamojski F, Nair V Nat Comput Sci. 2023; 3(7):644-657.

PMID: 37974651 PMC: 10653299. DOI: 10.1038/s43588-023-00476-5.


Unsupervised contrastive peak caller for ATAC-seq.

Vu H, Zhang Y, Tuteja G, Dorman K Genome Res. 2023; 33(7):1133-1144.

PMID: 37217250 PMC: 10538491. DOI: 10.1101/gr.277677.123.


References
1.
Moss D, Rickinson A, Pope J . Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer. 1979; 23(5):618-25. DOI: 10.1002/ijc.2910230506. View

2.
Gusella J, Wexler N, Conneally P, Naylor S, Anderson M, Tanzi R . A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983; 306(5940):234-8. DOI: 10.1038/306234a0. View

3.
Bird A, McLachlan S, Britton S . Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature. 1981; 289(5795):300-1. DOI: 10.1038/289300a0. View

4.
Miller G, Lipman M . Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A. 1973; 70(1):190-4. PMC: 433213. DOI: 10.1073/pnas.70.1.190. View

5.
Leapman S, Filo R, Smith E, Smith P . Differential effects of cyclosporin-A on lymphocyte subpopulations. Transplant Proc. 1981; 13(1 Pt 1):405-9. View